Cardiovascular risk of rosiglitazone: another perspective.
about
Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats.Diabetes mellitus: new challenges and innovative therapies.Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.Increased pulmonary vascular expression of Krüppel-like factor 5 and activated survivin in experimental congenital diaphragmatic hernia.
P2860
Cardiovascular risk of rosiglitazone: another perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular risk of rosiglitazone: another perspective.
@en
Cardiovascular risk of rosiglitazone: another perspective.
@nl
type
label
Cardiovascular risk of rosiglitazone: another perspective.
@en
Cardiovascular risk of rosiglitazone: another perspective.
@nl
prefLabel
Cardiovascular risk of rosiglitazone: another perspective.
@en
Cardiovascular risk of rosiglitazone: another perspective.
@nl
P2860
P356
P1476
Cardiovascular risk of rosiglitazone: another perspective.
@en
P2093
Javier C Waksman
P2860
P304
P356
10.1211/JPP.60.12.0002
P577
2008-12-01T00:00:00Z